104 related articles for article (PubMed ID: 38958516)
1. A Biochemical and Biophysical Analysis of the Interaction of nsp9 with nsp12 from SARS-CoV-2-Implications for Future Drug Discovery Efforts.
Baker DL; Wang B; Wilkinson-White LE; El-Kamand S; Allport TA; Ataide SF; Kwan AH; Artsimovitch I; Cubeddu L; Gamsjaeger R
Proteins; 2024 Jul; ():. PubMed ID: 38958516
[TBL] [Abstract][Full Text] [Related]
2. A structural analysis of the nsp9 protein from the coronavirus MERS CoV reveals a conserved RNA binding interface.
Mani G; El-Kamand S; Wang B; Baker DL; Ataide SF; Artsimovitch I; Cubeddu L; Gamsjaeger R
Proteins; 2024 Mar; 92(3):418-426. PubMed ID: 37929701
[TBL] [Abstract][Full Text] [Related]
3. Conserved Characteristics of NMPylation Activities of Alpha- and Betacoronavirus NiRAN Domains.
Slanina H; Madhugiri R; Wenk K; Reinke T; Schultheiß K; Schultheis J; Karl N; Linne U; Ziebuhr J
J Virol; 2023 Jun; 97(6):e0046523. PubMed ID: 37199624
[TBL] [Abstract][Full Text] [Related]
4. A natural product compound inhibits coronaviral replication in vitro by binding to the conserved Nsp9 SARS-CoV-2 protein.
Littler DR; Liu M; McAuley JL; Lowery SA; Illing PT; Gully BS; Purcell AW; Chandrashekaran IR; Perlman S; Purcell DFJ; Quinn RJ; Rossjohn J
J Biol Chem; 2021 Dec; 297(6):101362. PubMed ID: 34756886
[TBL] [Abstract][Full Text] [Related]
5. Coronavirus replication-transcription complex: Vital and selective NMPylation of a conserved site in nsp9 by the NiRAN-RdRp subunit.
Slanina H; Madhugiri R; Bylapudi G; Schultheiß K; Karl N; Gulyaeva A; Gorbalenya AE; Linne U; Ziebuhr J
Proc Natl Acad Sci U S A; 2021 Feb; 118(6):. PubMed ID: 33472860
[TBL] [Abstract][Full Text] [Related]
6. Dimerization of Coronavirus nsp9 with Diverse Modes Enhances Its Nucleic Acid Binding Affinity.
Zeng Z; Deng F; Shi K; Ye G; Wang G; Fang L; Xiao S; Fu Z; Peng G
J Virol; 2018 Sep; 92(17):. PubMed ID: 29925659
[TBL] [Abstract][Full Text] [Related]
7. The mechanism of RNA capping by SARS-CoV-2.
Park GJ; Osinski A; Hernandez G; Eitson JL; Majumdar A; Tonelli M; Henzler-Wildman K; Pawłowski K; Chen Z; Li Y; Schoggins JW; Tagliabracci VS
Res Sq; 2022 Feb; ():. PubMed ID: 35194601
[TBL] [Abstract][Full Text] [Related]
8. A distinct ssDNA/RNA binding interface in the Nsp9 protein from SARS-CoV-2.
El-Kamand S; Du Plessis MD; Breen N; Johnson L; Beard S; Kwan AH; Richard DJ; Cubeddu L; Gamsjaeger R
Proteins; 2022 Jan; 90(1):176-185. PubMed ID: 34369011
[TBL] [Abstract][Full Text] [Related]
9. The mechanism of RNA capping by SARS-CoV-2.
Park GJ; Osinski A; Hernandez G; Eitson JL; Majumdar A; Tonelli M; Henzler-Wildman K; Pawłowski K; Chen Z; Li Y; Schoggins JW; Tagliabracci VS
Nature; 2022 Sep; 609(7928):793-800. PubMed ID: 35944563
[TBL] [Abstract][Full Text] [Related]
10. Structural basis for dimerization and RNA binding of avian infectious bronchitis virus nsp9.
Hu T; Chen C; Li H; Dou Y; Zhou M; Lu D; Zong Q; Li Y; Yang C; Zhong Z; Singh N; Hu H; Zhang R; Yang H; Su D
Protein Sci; 2017 May; 26(5):1037-1048. PubMed ID: 28257598
[TBL] [Abstract][Full Text] [Related]
11. Severe acute respiratory syndrome coronavirus nsp9 dimerization is essential for efficient viral growth.
Miknis ZJ; Donaldson EF; Umland TC; Rimmer RA; Baric RS; Schultz LW
J Virol; 2009 Apr; 83(7):3007-18. PubMed ID: 19153232
[TBL] [Abstract][Full Text] [Related]
12. SARS-CoV-2 and SARS-CoV: Virtual screening of potential inhibitors targeting RNA-dependent RNA polymerase activity (NSP12).
Ruan Z; Liu C; Guo Y; He Z; Huang X; Jia X; Yang T
J Med Virol; 2021 Jan; 93(1):389-400. PubMed ID: 32579254
[TBL] [Abstract][Full Text] [Related]
13. Cryo-EM Structure of an Extended SARS-CoV-2 Replication and Transcription Complex Reveals an Intermediate State in Cap Synthesis.
Yan L; Ge J; Zheng L; Zhang Y; Gao Y; Wang T; Huang Y; Yang Y; Gao S; Li M; Liu Z; Wang H; Li Y; Chen Y; Guddat LW; Wang Q; Rao Z; Lou Z
Cell; 2021 Jan; 184(1):184-193.e10. PubMed ID: 33232691
[TBL] [Abstract][Full Text] [Related]
14. Coupling of N7-methyltransferase and 3'-5' exoribonuclease with SARS-CoV-2 polymerase reveals mechanisms for capping and proofreading.
Yan L; Yang Y; Li M; Zhang Y; Zheng L; Ge J; Huang YC; Liu Z; Wang T; Gao S; Zhang R; Huang YY; Guddat LW; Gao Y; Rao Z; Lou Z
Cell; 2021 Jun; 184(13):3474-3485.e11. PubMed ID: 34143953
[TBL] [Abstract][Full Text] [Related]
15. Development of novel monoclonal antibodies against nsp12 of SARS-CoV-2.
Machitani M; Takei J; Kaneko MK; Ueki S; Ohashi H; Watashi K; Kato Y; Masutomi K
Virol J; 2022 Dec; 19(1):213. PubMed ID: 36496472
[TBL] [Abstract][Full Text] [Related]
16. NMR-Based Analysis of Nanobodies to SARS-CoV-2 Nsp9 Reveals a Possible Antiviral Strategy Against COVID-19.
Esposito G; Hunashal Y; Percipalle M; Venit T; Dieng MM; Fogolari F; Hassanzadeh G; Piano F; Gunsalus KC; Idaghdour Y; Percipalle P
Adv Biol (Weinh); 2021 Dec; 5(12):e2101113. PubMed ID: 34705339
[TBL] [Abstract][Full Text] [Related]
17. A mechanism for SARS-CoV-2 RNA capping and its inhibition by nucleotide analog inhibitors.
Yan L; Huang Y; Ge J; Liu Z; Lu P; Huang B; Gao S; Wang J; Tan L; Ye S; Yu F; Lan W; Xu S; Zhou F; Shi L; Guddat LW; Gao Y; Rao Z; Lou Z
Cell; 2022 Nov; 185(23):4347-4360.e17. PubMed ID: 36335936
[TBL] [Abstract][Full Text] [Related]
18. SARS-CoV-2 NSP12 utilizes various host splicing factors for replication and splicing regulation.
Yang L; Zeng XT; Luo RH; Ren SX; Liang LL; Huang QX; Tang Y; Fan H; Ren HY; Zhang WJ; Zheng YT; Cheng W
J Med Virol; 2024 Jan; 96(1):e29396. PubMed ID: 38235848
[TBL] [Abstract][Full Text] [Related]
19. In silico evaluation of lapachol derivatives binding to the Nsp9 of SARS-CoV-2.
Junior NN; Santos IA; Meireles BA; Nicolau MSP; Lapa IR; Aguiar RS; Jardim ACG; José DP
J Biomol Struct Dyn; 2022 Aug; 40(13):5917-5931. PubMed ID: 33478342
[TBL] [Abstract][Full Text] [Related]
20. Lipopeptides against COVID-19 RNA-dependent RNA polymerase using molecular docking.
Xia B; Luo M; Pang L; Liu X; Yi Y
Biomed J; 2021 Dec; 44(6 Suppl 1):S15-S24. PubMed ID: 34871815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
